ArticleNutrition & metabolism2026
Skin carotenoids indicate diet, serum carotenoids, and inflammation across obesity and metabolic status in children.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Carotenoids in the Context of the Mediterranean Dietary Pattern: From Food Matrix and Bioavailability to Biomarkers and Human Health.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesTo validate reflection spectroscopy (RS)-based skin carotenoids (SCS) as non-invasive biomarkers of fruit and vegetable intake (FVI) in children and adolescents with obesity and metabolic dysfunction.
methodsThis case-control study (China, 2023) included 210 children and adolescents aged 7–17 years, categorized into five groups: healthy weight (n = 30), overweight (n = 23), obesity (n = 25), obesity with one metabolic disorder (n = 56), and obesity with two or more metabolic disorders (n = 76). SCS levels were measured using RS, FVI was assessed via a food frequency questionnaire, serum carotenoids were quantified by high-performance liquid chromatography, and inflammatory markers were analyzed using flow cytometry.
resultsSCS and serum carotenoid levels decreased significantly across groups (p for trend < 0.001). SCS correlated strongly with serum carotenoids, except for lycopene, with the strongest association observed in children and adolescents with obesity and two or more metabolic disorders. A quartile increase in FVI resulted in an 11.92–45.98 unit increase in SCS, partially mediated by total serum carotenoids, beta-carotene, and beta-cryptoxanthin. SCS also inversely correlated with inflammation in metabolically disordered groups.
conclusionsRS-based SCS is a valid, non-invasive biomarker of FVI, closely related to serum carotenoids and inflammatory status, and effectively distinguishes metabolic dysfunction in children and adolescents.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.